Korotkoff Sounds and Dual Auscultation: The Reference Behind Blood Pressure Validation

Blood pressure validation studies depend on a reference method that is clinically grounded and repeatable. For intermittent blood pressure devices, that reference is often manual auscultation, where trained observers use a cuff and stethoscope to determine systolic and diastolic pressure based on Korotkoff sounds. 

These sounds provide the clinical signal used to identify the points at which blood flow first returns and then becomes silent again as the cuff deflates. For intermittent automated cuff-based blood pressure devices, ISO 81060-2 uses auscultatory reference measurements collected under standardized conditions to support comparison of device readings. 

At Parameters Research Laboratory (PRL), auscultatory reference measurements are performed within tightly controlled study environments designed to support regulator-ready blood pressure validation. Our team applies standardized observer training, protocol-defined measurement sequencing, and rigorous quality controls to help Sponsors generate reliable comparison data for FDA and CE mark submissions. 

What Are Korotkoff Sounds? 

Korotkoff sounds are the sounds produced by blood flow in an artery as a blood pressure cuff is slowly deflated. When cuff pressure is above systolic pressure, the artery is occluded, and no flow-related sounds are heard. As cuff pressure falls, blood begins to pass through the partially compressed artery, producing distinct sound phases that can be used to determine blood pressure values. 

• Systolic blood pressure (SBP) is identified at Korotkoff Phase I, the first clear tapping sound  

• Diastolic blood pressure (DBP) is identified at Korotkoff Phase V, when the sound disappears  

  
  

Because these sounds serve as the clinical reference for intermittent cuff-based devices, observer consistency and environmental control are critical during validation studies. PRL’s experience conducting physiological monitoring studies supports careful implementation of auscultatory methods under standardized conditions aligned with ISO 81060-2 expectations. 

Dual Auscultation as a Reference Measurement 

Dual auscultation is used in clinical validation studies to strengthen the reliability of the auscultatory reference. Instead of relying on a single observer, two trained observers independently determine SBP and DBP while listening to the same measurement event. This approach reduces individual observer bias and supports more consistent reference determination across repeated measurements. 

Dual auscultation is commonly performed using a shared-listening setup, so both observers hear the same Korotkoff sounds simultaneously. Independent readings are then compared, and prespecified agreement rules are applied to confirm that the reference value is acceptable for analysis. 

PRL incorporates documented observer qualification procedures and standardized measurement workflows to support reproducibility across study participants and study visits. Our team also develops protocol-specific measurement procedures that align with Sponsor objectives, device characteristics, and regulatory expectations. 

For Sponsors preparing for FDA submission or CE mark activities, a consistent reference methodology can help reduce avoidable data variability that may complicate performance analysis or delay review timelines. 

Practical Considerations for Auscultatory Reference Measurements 

Korotkoff sound detection can be influenced by technique and study conditions, which is why validation protocols standardize key factors such as: 

• Seated posture, back support, and arm position at heart level  

• Defined rest periods and no talking during measurements  

• Correct cuff sizing and consistent cuff placement  

• Observer training and documented procedures  

• Repeatable deflation rate and measurement sequencing  

  
  

These controls reduce avoidable variability and help ensure reference measurements are consistent across participants and study visits. 

PRL’s clinical operations team supports these controls through detailed protocol development, study staff training, and quality-focused execution practices. Our experience with physiological monitoring studies allows us to help Sponsors implement workflows that support accurate reference measurements while maintaining good clinical practice (GCP) and ISO 14155-aligned study conduct. 

In addition to blood pressure validation expertise, PRL has extensive experience supporting wearable and physiological monitoring technologies through regulator-ready data collection strategies, protocol optimization, and transparent CRO collaboration. 

Why Reference Quality Matters for Device Validation 

Automated blood pressure devices are evaluated against the auscultatory reference method, meaning the quality of the reference measurement directly affects study interpretability. Even a well-designed device can appear inconsistent if reference measurements are poorly standardized or observer agreement is weak. 

High-quality reference methodology helps Sponsors: 

• Improve confidence in performance evaluation  

• Reduce unnecessary data exclusions  

• Support clearer statistical interpretation  

• Strengthen documentation for regulatory review  

• Minimize avoidable FDA submission delays  

  
  

PRL’s approach emphasizes protocol alignment, operational transparency, and careful execution to support reliable clinical validation outcomes. 

Conclusion 

Korotkoff sounds remain the clinical basis for determining systolic and diastolic blood pressure during manual auscultation. In device validation studies, dual auscultation strengthens this reference method by improving consistency, reducing observer-driven variability, and supporting clear documentation aligned with standards such as ISO 81060-2. 

For intermittent blood pressure devices, this approach helps generate reliable reference values that support accurate, interpretable performance evaluation and regulator-ready reporting. 

Sponsors developing blood pressure monitoring technologies need a clinical research partner that understands both the scientific and operational requirements of validation studies. Contact PRL to discuss your blood pressure validation study, protocol strategy, and regulatory submission goals.